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Objectives: To explore whether differences between national cultures as described in 
Hofstede’s model of cultural dimensions (Power Distance, Individualism, Masculinity and 
Uncertainty Avoidance) are associated with cross-national differences in use of antibiotics 
(prescribed and non-prescribed). 
Methods: A survey on reported use of systemic antimicrobial drugs in the last 12 months (SAR-
study) was conducted in 19 European countries. Country-level data from this survey were 
correlated to country-specific scores of cultural dimensions obtained from Hofstede. Results 
were verified by doing the same for data from 3 other studies on antibiotic use. 
Results: The SAR-study resulted in a response rate higher than 20% in 17 countries for which 
scores on the cultural dimensions were also available. The three other studies provided data on 
antibiotic use for 27 European countries in total, for which scores of cultural dimensions were 
also available. Significant positive correlations were found between Power Distance and 
prescribed (0.59) and non-prescribed (0.54) use of antibiotics. Data from the other 3 studies 
gave similar results. Uncertainty Avoidance was not significantly correlated with the data on 
antibiotic use from the SAR-study but was significantly positively correlated to the antibiotic 
use as reported in the three other studies. Individualism was significantly negatively correlated 
with self-medication (-0.41), but not with prescribed antibiotics. No significant correlations 
between Masculinity and antibiotic use were found. 
Conclusions: Of the dimensions of national culture, in particular Power Distance seems to be 
associated with antibiotics use. Campaigns aimed at more rational antibiotics use thus require 
good understanding of national culture. 
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Introduction 
Antibiotics are important and widely used medicines (1,2). There is, however, a growing 
concern that the use and especially the unnecessary use of these medicines leads to resistance, 
avoidable costs and adverse reactions (1-3). Hence, a more prudent use of antibiotics has been 
advocated (4).  
There are considerable cross-national differences in public attitudes towards antibiotics 
use (5) as well as in actual use of prescribed antibiotics (2,6,7) and self-medications with 
antibiotics (8). These cross-national differences in use of antibiotics can only partially be 
explained by epidemiological differences and differences in health care structure. Cultural 
factors also are known to play an important role in illness behaviour and consumption of 
antibiotics (9). Most cross-cultural comparisons are about factors directly related to illness 
behaviour (e.g. labelling and presumed causes of illnesses). Few studies have explored the 
broader and general cultural characteristics of a country that at first sight are not directly 
related to illness behaviour (10). One of the difficulties in many studies is that the concept of 
culture is often used as a general concept for all inexplicable cross-national differences. It is 
also hard to operationalise the concept of culture into quantifiable measures that can be used 
in comparative studies.  
A possible solution is the use of cultural dimensions. These dimensions are aspects from 
which a culture can be compared with other cultures. They provide a relatively general 
framework for analysis that can be easily applied because it reduces the complexities of culture 
and its interactions into quantifiable dimensions (11-13). Based on surveys in more than 50 
countries, Hofstede initially found 4 cultural dimensions on which countries can be scored: (i) 
Power Distance, (ii) Individualism, (iii) Masculinity and (iv) Uncertainty Avoidance. Power 
Distance refers to the degree of hierarchy in a country, it has been defined by Hofstede as the 
extent to which the less powerful members of organizations and institutions accept and 
expect that power is distributed unequally. Individualism refers to the prevalence of the 
interests of an individual versus the group. This dimension is defined as the degree to which 
individuals are integrated into groups. Masculinity, as opposed to femininity, refers to a culture 
in which the emotional roles between the genders are clearly separated; masculine cultures are 
for instance very assertive and competitive. Uncertainty Avoidance deals with a society's 
tolerance for uncertainty and ambiguity; this cultural dimension indicates to what extent a 
culture programs its members to feel either uncomfortable or comfortable in novel, unknown 
or surprising situations. Later, a fifth dimensions (Long Term versus Short Term Orientation) 
was found, based on Asian studies. While the influence of cultural dimensions on illness 
behaviour and use of medicines has been suggested in previous studies (14,15), very few studies 
have actually linked the scores on cultural dimensions with diseases and illness behaviour (16) 
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and, to our knowledge,  no study did this with regard to use of antibiotics. The aim of this study 
is to explore whether cultural dimensions, are associated with cross-national differences in the 
prescribed use of antibiotics and self-medication with antibiotics.  
Materials and methods 
Data on prescribed use of antibiotics and self-medication were obtained from a survey in 
2003 on reported use of systemic antimicrobial drugs in the last year in 19 European countries 
(SAR: Self-medication with antibiotics and Resistance in Europe). A multistage sampling design 
was used in each participating country. Within each country, a region with average prescribed 
antibiotic consumption was chosen, based on available national data on use of medicines. In 
each region an urban (with a population 75,000- 350,000) and a rural area (population 5,000- 
10,000) were selected. Persons > 18 years of age were randomly selected from population 
registries in the selected regions. The questionnaire was developed specifically for this survey 
in English, translated into national languages, and back-translated for consistency. The 
questionnaire is available in English from the corresponding author. More information is 
provided elsewhere (8). Respondents were classified as self-medicating if they reported that 
they had taken any antimicrobial drugs in the previous 12 months without a prescription from a 
physician, dentist, or nurse and as prescribed users if antimicrobial drugs had been prescribed. 
For all countries in the SAR-study with a response rate higher than 20%, prevalence of reported 
self-medication and prescribed use of antibiotics in the previous 12 months per 1000 
population were estimated (8). To verify whether the findings based on our data were 
consistent with results based on other studies and other European countries, we also made use 
of country-data on outpatient antibiotic use published by the European Surveillance on 
Antimicrobial Consumption (2), on reported use of antibiotics in the last year published by 
Eurobarometer (7), and on outpatients antibiotics sales using IMS data (6).  In contrast to the 
data of the SAR-study, these other studies could not differentiate between prescribed 
antibiotics and self-medication with antibiotics. 
Data on cultural dimensions were obtained from Hofstede (13). We only used the 4 initial 
dimensions because data about the fifth dimension (Long Term Orientation) were only 
available for a limited number of countries. Scores on these dimensions, called indexes, 
indicate the relative positions of countries with regard to each other. For an initial set of 40 
countries they were derived from carefully matched samples of employees in different national 
subsidiaries of the same multinational corporation (17). These relative positions turned out to 
be remarkably stable over time; they were replicated in a number of successive studies by 
different researchers using a variety of other matched samples of respondents (for an overview 
see Hofstede, 2001). Later additions used a simplified questionnaire, the Values Survey Module 
1994 (18). It consists of 20 content questions and 6 demographic questions. The most recently 
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published lists contain index values on the first four dimensions for 74 countries and regions 
(13). Spearman’s correlation coefficient rho was used to calculate correlations between country-
aggregated use of antibiotics and country-specific scores of cultural dimensions. 
 
Results 
There were 17 countries from the SAR-study (including 14,877 respondents) for which we 
had information on reported self-medication with antibiotics, prescribed use of antibiotics in 
the last 12 months and the scores on Hofstede’s cultural dimensions (table 1). Via the ESAC-
study (24 countries), the Eurobarometer study (15 countries) and the study by Cars et al (15 
countries) we disposed over similar data for in total 27 European countries (2,6,7).  
Significant positive correlations were found for Power Distance Index with prescribed use 
of antibiotics (0.59) and self-medication (0.54). Comparison with data available from other 
studies and other countries demonstrated significant correlations in the same directions (table 
2). The Individualism Index is significantly negatively correlated with self-medication of 
antibiotics (-0.41). Moderate but non-significant correlations were found for prescribed use in 
the SAR-study and antibiotic use as reported in the other 3 studies. The Masculinity Index 
correlates moderately but non-significantly with self-medication (0.31) and prescribed use 
(0.42). This is consistent with the correlations based on the other studies. The finding of a 
positive correlation of Uncertainty Avoidance Index with self-medication (0.43) and prescribed 
use (0.32) is consistent with those of the other data sets. The correlations based on data of the 
SAR-study are however not significant, which they are for the data based on the other studies. 
The differences between correlation coefficients for prescribed use and self-medication are 
very small with regard to Power Distance and Individualism. For Masculinity and Uncertainty 
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**  Correlation is significant at the 0.01 level (2-tailed). 
*  Correlation is significant at the 0.05 level (2-tailed). 
Discussion 
Power distance is positively correlated with self-medication and prescribed use of 
antibiotics in all the data sets. Uncertainty Avoidance, at first sight, does not seem to be 
relevant but significant positive correlations were found with antibiotic use as reported in 
other previous studies (partially based on other European countries). The findings for the 





In countries with a high Power Distance inequality is expected and preferred. 
Subordinates will expect their superior to tell them what to do.  In countries with a low Power 
Distance, to the contrast, people in less powerful positions will feel less dependent of more 
powerful people. They are expected to take initiatives and there is a preference for 
consultation. This may have implications for collaboration between doctors and other health 
care providers, such as pharmacists and nurses, as well as in the doctor-patient 
communication. An example of the former, is the collaboration between physicians and 
pharmacists. In countries with high Power Distance, hierarchic differences will be more 
manifested and doctors will have a more pronounced (therapeutic) autonomy, in other 
countries doctors feel more part of a team. In the Netherlands (a country with a low Power 
  Power 
Distance 
Individualism  Masculinity Uncertainty 
Avoidance 
SAR data 
    Self-medication 
    Prescribed use 













    ESAC (N=24) 0.59** -0.29 0.22 0.59** 
    Eurobarometer (N=15) 0.62* -0.30 0.31 0.58* 
    Cars et al. (N=15) 0.78** -0.38 0.16 0.78** 
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Distance and one of the lowest use of antibiotics) Pharmacotherapy Counselling Groups, in 
which GPs and local community pharmacists regularly meet to exchange information about 
drug therapy, has been the spearhead of a successful policy for more rational use of antibiotics 
and other medicines (10,19,20). Power Distance will also affect the doctor patient- relationship, 
besides the relations between professionals. In countries with a high Power Distance patients 
look up to their doctor. They expect great expertise of them and feel little need for being 
involved in the decision-making. Asking “what do you think yourself of taking an antibiotic?” 
would embarrass the ‘modal’ patient. Either so, a physician acknowledging that he is not sure 
whether it is a viral or bacterial infection and hence says: “well, let us wait and see” will, in such 
a cultural context, not inspire much confidence. Prescribing antibiotics has strong symbolic 
connotations and it can be seen as a sign of power and expertise. Hence, antibiotics not only 
have a pharmaceutical but also a communicative aspect. The clinician-patient encounter has 
been described as ‘one of the most important battlegrounds’ in the struggle with the microbe 
(21). Countries with low Power Distance, to the contrast, show a preference for shared decision-
making in which the patient discloses his concerns and point of view, e.g. with regard to pros 
and cons of antibiotics. It is true that patients often put pressure on the physician to prescribe 
antibiotics but doctors often overestimate patients demand (22). Taking the time to talk about 
patients concerns and to make patient expectations explicit has been promoted as a good 
strategy to attain a more rational use of antibiotics (23-26). The finding that Power Distance is 
relevant with regard to use of antibiotics is in line with other studies (24) that indicate that 
doctor-patient relationship and dissatisfaction with the doctor is an important determinant of 
antibiotic misuse. Of four types of patients (involved, deferent, ignored and critical types), the 
Involved, i.e. patients which ensure they are part of the decision-making process and seeing 
themselves as equal to the doctor, have views on and use of antibiotics most in line with the 
medical views. Therefore, changing the patient to the more involved type is suggested as a 
strategy to limit the use of antibiotics. However this might be more difficult in countries with 




Uncertainty Avoidance deals with a society's tolerance for uncertainty and ambiguity. 
Typically, people in such societies can accept known risks but they try to avoid unclear situation 
and want to have control over things. If applied to medical situations, patients and physicians 
will have an aversion to diagnostic uncertainty and will prefer a clear labelling of diseases. 
However, many symptoms, such as coughing, sore throat, mild fever, etc. are difficult to label 
and remarkable cross-cultural variations have been found (14,27). Based on a clinical 
examination of the patient, it is often impossible to determine whether the problem is caused 
by a (self-limiting) viral infection or a bacterial infection, in which cases antibiotics might be 
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warranted (28). Hence, it is usually good practice to ‘wait and see’. However, there is always a 
small risk of a dangerous infection. If doctor and patient are not willing to accept risks, they 
rather start using antibiotics immediately, likely with a preference to the newest and strongest 
broad spectrum antibiotics. When the Uncertainty Avoidance is high, rather than returning 
home with the message that ‘the doctor does not know’ neither what disease they have, nor 
how to cure it, they accept the known risks of using antibiotics. In the latter case, patients feel 
confident that they have a disease with a clear cause that is under control. The above attitude 
of avoiding any risk is known as defensive medicine and leads to unnecessary high medical 
consumption (29).  
 
Prescribed use versus self-medication 
 
We found little differences between the effects of cultural dimensions on prescribed use 
versus self-medication of antibiotics. This suggests that in countries with high incidence of 
self-medication with antibiotics, the prescription of antibiotics is also high and that self-
medication and prescribing are practices affected by the same cultural dimensions. This adds 
evidence to the hypothesis that notwithstanding the physician is formally the only person to 
decide whether or not antibiotics should be used, the final decision is the result of a complex 
interaction between patient and physicians in a particular cultural context. There is no 
indication in our data that behaviour with regard to use of antibiotics of physicians is less 
dependent of the local cultural context than that of the lay people (the patients). 
Our study had some limitations. First, the response rate for the SAR data was low in some 
countries. We therefore repeated the analysis, limited to countries with response rates of 
>40%. We also plotted the results and checked for the effect of possible outliers. These 
verifications corroborated our results. Second, culture is certainly a much richer phenomenon 
than the presented reduction into 5 dimensions and Hofstede has been criticized for trying ‘to 
measure the immeasurable’ (30,31). However, equivalents of Hofstede’s cultural dimensions 
were found by several other authors and the cultural dimensions were validated in multiple 
other studies (12). An advantage of the use of cultural dimensions is that they enable 
quantitative analysis of cultural aspects in relation to other relevant issues such as the use of 
antibiotics (11). This is not possible using thicker descriptions of cultures, i.e. anthropological 
descriptions based on qualitative data.  
In summary, our study indicates that Power Distance is a cultural aspect associated with 
antibiotic use, suggesting that the culturally-specific way people deal with authority is an 
important factor in explaining cross-national differences in antibiotic use. Uncertainty 
Avoidance can lead to defensive medicine which might result in unnecessary use of antibiotics. 
Further cross-national comparative research is needed to better understand the correlations 
between the cultural dimensions and the use of antibiotics and the reasons for this so that our 
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hypothetical explanations can be corroborated or falsified. These findings and the deduced 
explanations suggest that countries are likely to react differently on campaigns aiming at a 
more rational use of antibiotics. It should be taken into account that cultural dimensions can 
be obstacles or facilitators which, by their nature, are hard to change (26,32). The 
understanding of the effect of cultural dimensions might explain why campaigns are less 
successful in some countries than in others (21, 26, 33-35). A better understanding of cultural 
dimensions can be used to anticipate reactions to a campaign in a particular country. For 
example, our results suggest that in countries with low Power Distance, campaigns for more 
appropriate use of antibiotics should involve both professionals and the general public, while 
in countries with high Power Distance campaigns to improve antibiotic use should focus 
primarily at the physicians.  
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